become coated with a continuous bony layer, resembling sugar-icing (Zuckerguss) . At the level of the vertebral body the bridging is a few millimetres thick, while across the intervertebral space it may be several centimetres thick. These ossifications may extend over two vertebrae or more and sometimes involve the whole thoracic spine. They tend to be more marked on the right side, since on the left side the pulsation of the aorta interfers with their formation ( Fig. 2a and b, overleaf).
In the lumbar spine, these bony outgrowths are often discontinuous; they may be shaped like a candle-flame or the snout of a tapir, and may project upwards or downwards. In the lumbar region they develop on both the right and left sides (Fig. 3, overleaf) .
In the cervical spine (Fig. 4, overleaf) , there may be continuous ossification, or bridging similar to that in the lumbar region.
There is no ankylosis of the intervertebral and costovertebral joints, like that characteristic of ankylosing spondylitis, no ossification of the short spinal ligaments, and no obliterations of the sacroiliac joints like that seen in ankylosing spondylarthritis (Fig. 5, overleaf) .
On the basis of the findings of de Seze, Lacapere, and Amoudruz (1952) , who studied the embryonic development of the spinal column, Ott (1953) Ott (1953) , Vignon, Durant, Pansu, Bertrand, and Truchot (1961) and Smith, Pugh, and Polley (1955) suggested that it is merely one form of spinal degeneration, differing only quantitatively from the common spondyloses. Rubens-Duval, Villiaumey, and Lubetzki (1961) suggested that this hyperostosis of the spine is due to dystrophies affecting the somatic growth in adolescence and develops in later life when the spinal column is subjected to excessive strain.
Boulet, Serre, and Mirouze (1954) , Serre and Mirouze (1955) , and Mirouze (1961) the enzyme hexokinase, acting as a catalysator during the formation of glucose-6-phosphoric acid from glucose and from adenosine triphosphoric acid. In older people the diabetogenic action of the growth hormone may be due either to its action on the carbohydrate metabolism by depressing the secretion of insulin, or by influencing the peripheral utilization of glucose through the inhibition of hexokinase activity. Through a mobilization of lipids and an excessive oxidation of fats, the growth hormone actually increases the severity of symptoms caused by a deficiency of insulin (Straub, 1960) .
According to Boulet and others (1954), Serre and Mirouze (1955) , and Ott, Schwenkenbecher, and Iser (1963) , both the diabetogenic disturbance and the increased osteoplastic activity of the subligamentous connective tissue may be due to a common factor, i.e. to the increased output of the growth hormone. Osteoporosis of the spinal column was the first spinal disease reported in association with diabetes mellitus; its development was explained as due to metabolic and endocrine disturbances and the presence of mild pain was attributed to diabetic neuropathy.
Boulet, Serre, Mirouze, and Mandin (1953) Ott (1964) and Ott and others (1963) , and in Czechoslovakia by Weiszer, 'Durco, and Kratinova (1964) . Ott and others (1963) found a hyperostotic spondylosis in almost 50 per cent. of 82 patients with clinically manifest diabetes; this series included old people with a benign type of diabetes. According to Boulet and others (1954) , hyperostotic changes may develop as late as 12 years after the onset of diabetes; they are not confined to the spine and develop in various sites. Ott and others (1963) and Einaudi and Viara (1960) reported that, in many patients with hyperostotic spondylosis, the glucose tolerance test yielded a hyperglycaemic curve. Ott and others (1963) observed this phenomenon in 25 out of 100 patients suffering from hyperostosis, but Klunker (1964) found no positive correlation between hyperostotic spondylosis and a disturbance of the carbohydrate metabolism.
During the study of spinal hyperostosis, we have tried to ascertain whether diabetes had any influence on its development. We have investigated altogether 101 diabetics whose ages ranged from 40 to 86 years (including 44 patients treated at our Institute for diseases of the locomotor system and 57 patients followed-up at an out-patient department for diabetes).
The Table shows that 83 of our 101 patients were women whereas Ott's series consisted mainly of men. We found hyperostotic spondylosis in six of eighteen men and in 34 of 83 women (i.e in 41 per cent. of females and 33 * 3 per cent. of males). The mean age of the diabetics with hyperostotic spondylosis was higher than that of those without.
The incidence of hyperostotic spondylosis is compared with the duration of diabetes and the age of the patients in Fig. 6 , which shows that the older the patient and the longer the duration of diabetes, the higher was the frequency of hyperostotic spondylosis.
In our series of hyperostotic and diabetic patients, the diabetes was mild or moderately severe, of the so-called sthenic form. Eighteen cases were controlled by dietary restriction alone, eleven took antidiabetic drugs by mouth and eleven received insulin up to 40 units/day. The associated complications were compatible with the advanced age of the patients as well as with the underlying disease. The most common were cardiovascular diseases (hypertension, ischaemic heart disease, myocardial infarction, endarteritis, systemic arteriosclerosis, thrombophlebitis), slightly less frequent were cholecystopathies, diabetic polyneuritis, and retinopathies, and there was one case of a diabetic pseudotabes. There were also a few cases of pulmonary or spinal tuberculosis, Reiter's syndrome, infectious hepatitis, gastric ulcer, and pyelonephritis. Two cases of vascular nephropathy included one early stage and one suspected Kimmelstiel-Wilson's glomerulo-hyalinosis.
Conclusion
There are no substantial differences between the radiological appearances and the clinical symptoms of hyperostotic spondylosis in patients with and without diabetes mellitus. Although a disturbance of the carbohydrate metabolism cannot be the unique aetiological factor responsible for the development of hyperostotic spondylosis, the relatively high incidence of this spinal condition in diabetics dorsal. Su etiologia no se conoce, pero se sugiere que la diabetes mellitus (un 40 por ciento en nuesta serie de 101 secreci6n aumentada de la hormona hipofisaria de diab_ticos). Los enfermos de edad mas avanzada, cuya crecimiento pudiera favorecer la produccion de estas diabetes habia empezado mas tarde y fue benigna aunque osificaciones paravertebrales. La espondilosis hipero-prolongada, acusaban una frecuencia mayor de hiperost6sica es relativamente frecuente en enfermos con stosis vertebral.
